Literature DB >> 32302024

COVID-19 and ischemic heart disease emergencies: What cardiac surgery should expect?

Emanuele Pilato1, Rachele Manzo1, Giuseppe Comentale1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32302024      PMCID: PMC7262349          DOI: 10.1111/jocs.14556

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


× No keyword cloud information.
To the Editor, Back to the past? The incidence of mechanical complications of acute coronary syndromes (ACS) needing cardiac surgery has reduced significantly in the last years due to early diagnosis and treatments. Primary coronary angioplasty of culprit lesions, indeed, allowed rescue of vital myocardium after ACS with significant impact on the functional recovery of the heart and long‐term morbidity. COVID‐19 pandemic may oddly lead to a changing scenario and significantly modify the cardiac surgery population that we will be dealing within the next weeks. The widespread demand for intensive and subintensive care beds, as well as a cardiac tropism of SARS‐CoV‐2, has brought to an extensive reassessment of hospitals and emergency rooms (ERs) into COVID‐dedicated structures, making them potential contagion areas. In Italy, for example, more than 10% of patients with COVID are health care providers showing how a severe protection policy among hospitals staff is mandatory to protect not only themselves but all kinds of patients. In support of this, “Cotugno” Infectivological Hospital of Napoli, through the highest protection/decontamination protocols, is the only Italian hospital without health care SARS‐CoV‐2 infections. This phenomenon, therefore, would generate in the patients a sense of fear regarding access to the ERs: the patient with an ACS, indeed, especially diabetic ones, probably ends up underestimating symptoms such as chest pain or angina equivalents and not going to the ER quickly, relying on home remedies. This behavior, contrary to what would be expected given the current predilection of an endovascular treatment of ACSs aimed at minimizing the impact on intensive care, could frustrate the prevention strategies based on the earliness of intervention implemented in these years and thus creating a vast pool of patients who will enter the hospital in more critical situations and with mechanical complications of an evolving ACS. Papillary muscles ruptures and acute mitral regurgitations, ruptures of the interventricular septum or of the walls of the heart, in fact, together with the aneurysmal dilations of untreated necrotic areas could become an important part of the cardiac surgery population in the next weeks. For this purpose, strategies concerning people's education and centralization of cardiovascular care toward “protected” structures could restore the patient's confidence in going to the ERs at an early stage of symptoms and stem a phenomenon that could trigger an important increase in cardiovascular morbidity and mortality.
  2 in total

1.  The Variety of Cardiovascular Presentations of COVID-19.

Authors:  Justin A Fried; Kumudha Ramasubbu; Reema Bhatt; Veli K Topkara; Kevin J Clerkin; Evelyn Horn; LeRoy Rabbani; Daniel Brodie; Sneha S Jain; Ajay J Kirtane; Amirali Masoumi; Koji Takeda; Deepa Kumaraiah; Daniel Burkhoff; Martin Leon; Allan Schwartz; Nir Uriel; Gabriel Sayer
Journal:  Circulation       Date:  2020-04-03       Impact factor: 29.690

2.  Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID-19.

Authors:  Giuseppe Tarantini; Chiara Fraccaro; Alaide Chieffo; Alfredo Marchese; Fabio Felice Tarantino; Stefano Rigattieri; Ugo Limbruno; Ciro Mauro; Alessio La Manna; Battistina Castiglioni; Matteo Longoni; Sergio Berti; Francesco Greco; Giuseppe Musumeci; Giovanni Esposito
Journal:  Catheter Cardiovasc Interv       Date:  2020-04-11       Impact factor: 2.585

  2 in total
  2 in total

1.  Mechanical Complications of Acute Myocardial Infarction during the COVID-19 Pandemic.

Authors:  Ting-Wei Lin; Meng-Ta Tsai; Hsuan-Yin Wu; Jun-Neng Roan; Chwan-Yau Luo
Journal:  Acta Cardiol Sin       Date:  2021-01       Impact factor: 2.672

2.  Acute Brain Ischemia, Infarction and Hemorrhage in Subjects Dying with or Without Autopsy-Proven Acute Pneumonia.

Authors:  Thomas G Beach; Lucia I Sue; Anthony J Intorcia; Michael J Glass; Jessica E Walker; Richard Arce; Courtney M Nelson; Geidy E Serrano
Journal:  medRxiv       Date:  2021-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.